Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.53 USD | -4.08% | -12.19% | +557.36% |
31/05 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
14/05 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+557.36% | 20Cr | |
+18.72% | 13TCr | |
+14.19% | 11TCr | |
-4.93% | 2.46TCr | |
+3.23% | 2.28TCr | |
-10.44% | 1.82TCr | |
-41.74% | 1.65TCr | |
-13.31% | 1.65TCr | |
+2.44% | 1.34TCr | |
+27.89% | 1.11TCr |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Elevation Oncology Halts Investment in Seribantumab; Plans 30% Workforce Cut; CEO Shawn Leland Resigns